Correlation Between Aclaris Therapeutics and Genetron Holdings
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Genetron Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Genetron Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and Genetron Holdings, you can compare the effects of market volatilities on Aclaris Therapeutics and Genetron Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Genetron Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Genetron Holdings.
Diversification Opportunities for Aclaris Therapeutics and Genetron Holdings
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aclaris and Genetron is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Genetron Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genetron Holdings and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Genetron Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genetron Holdings has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Genetron Holdings go up and down completely randomly.
Pair Corralation between Aclaris Therapeutics and Genetron Holdings
If you would invest (100.00) in Genetron Holdings on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Genetron Holdings or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Aclaris Therapeutics vs. Genetron Holdings
Performance |
Timeline |
Aclaris Therapeutics |
Genetron Holdings |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Aclaris Therapeutics and Genetron Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aclaris Therapeutics and Genetron Holdings
The main advantage of trading using opposite Aclaris Therapeutics and Genetron Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Genetron Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genetron Holdings will offset losses from the drop in Genetron Holdings' long position.Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
Genetron Holdings vs. Sera Prognostics | Genetron Holdings vs. DarioHealth Corp | Genetron Holdings vs. Biodesix | Genetron Holdings vs. Aclaris Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |